Sarepta Therapeutics, Inc. Quarterly Operating Margin in % from Q3 2017 to Q4 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Sarepta Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q3 2017 to Q4 2024.
  • Sarepta Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was 11.5 %.
  • Sarepta Therapeutics, Inc. annual Operating Margin for 2024 was 11.5 %.
  • Sarepta Therapeutics, Inc. annual Operating Margin for 2023 was -21.5 %, a 62.5% increase from 2022.
  • Sarepta Therapeutics, Inc. annual Operating Margin for 2022 was -57.5 %, a 12.3% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.